Monday, November 14, 2022
- 1:00PM-3:00PM
-
Abstract Number: 2064
Trajectories of Disease Activity in a Longitudinal Registry of Pediatric SLE
SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes- 1:00PM-3:00PM
-
Abstract Number: 1934
Transition Readiness Before versus After Adolescents with Rheumatic Disease Transition to Adult Care
Pediatric Rheumatology – Clinical Poster III: Other- 1:00PM-3:00PM
-
Abstract Number: 1761
Treatment Patterns of Disease-Modifying Anti-Rheumatic Drugs by Serostatus Among Patients with Rheumatoid Arthritis
Epidemiology and Public Health Poster III- 1:00PM-3:00PM
-
Abstract Number: 1843
Trends in the Cumulative Exposure to Corticosteroids in Polymyalgia Rheumatica (PMR) Patients: A Single Academic Center Experience
Miscellaneous Rheumatic and Inflammatory Diseases Poster III- 1:00PM-3:00PM
-
Abstract Number: 1790
Ultrasound Diagnosis of Calcium Pyrophosphate Crystal Deposition: Which Sites Should Be Scanned?
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster- 1:00PM-3:00PM
-
Abstract Number: 1919
Underdiagnosis and Undertreatment of Knee Osteoarthritis in Persons with Type 2 Diabetes: A Cross-sectional Study
Osteoarthritis – Clinical Poster- 1:00PM-3:00PM
-
Abstract Number: 2076
Unfavorable Outcomes Associated with Current Standard of Care in the Management of Patients with Systemic Lupus Erythematosus
SLE – Diagnosis, Manifestations, and Outcomes Poster III: Outcomes- 1:00PM-3:00PM
-
Abstract Number: 1823
Unsupervised Cluster Analysis of Clinical and Ultrasound Features Reveals Unique Gout Subtypes: Results from the Egyptian College of Rheumatology (ECR)
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster- 1:00PM-3:00PM
-
Abstract Number: 1811
Urate Lowering Therapy Initiation in Hospitalized Patients with Acute Gout Flares
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster- 1:00PM-3:00PM
-
Abstract Number: 1828
Urate-lowering Therapy Reduces Non-Episodic Foot Pain in Patients Who Fail to Meet ACR/EULAR 2015 Gout Classification Criteria: An Effect Predicted by Ultrasound
Metabolic and Crystal Arthropathies – Basic and Clinical Science Poster- 1:00PM-3:00PM
-
Abstract Number: 1859
Urinary Beta-2 Microglobulin Is a Sensitive Prognostic Marker in Dermatomyositis Patients with Interstitial Lung Disease Positive for Anti-MDA-5 Antibody
Muscle Biology, Myositis and Myopathies Poster II- 1:00PM-3:00PM
-
Abstract Number: 1978
Using Administrative Health Data to Construct a Frailty Index as a Measure of Susceptibility to Adverse Health Outcomes Among Individuals with Rheumatoid Arthritis
RA – Diagnosis, Manifestations, and Outcomes Poster IV- 1:00PM-3:00PM
-
Abstract Number: 1764
Utilization of Electronic Health Record Data to Evaluate the Impact of Urban Environment on Risk of Systemic Lupus Erythematosus Symptoms